Kelly Birch, MPH

Senior Manager, HEOR

Kelly Birch headshot - woman with blonde hair smiling for headshot

Kelly Birch, MPH is a Senior Manager, Health Economics and Outcomes Research at Inovalon. She supports the design, execution, and project management of real-world data (RWD) analyses that aid healthcare and life sciences companies in their mission to improve patient care.

Prior to joining Inovalon, Kelly served as a Senior HEOR Writer at OPEN Health Scientific Communications, partnering with life sciences companies on strategic publication planning and scientific content development. She previously held a Senior Research Scientist role at PRECISIONheor, where she worked on the design, execution, and dissemination of diverse HEOR projects that included patient-reported outcomes assessment, qualitative research, economic evaluations, and real-world database analyses using administrative claims and electronic health record data. Her HEOR experience spans numerous therapeutic areas including oncology, psychiatry, chronic disease, infectious disease, and rare disease.

Kelly has co-authored numerous conference presentations as well as several peer-reviewed manuscripts published in journals such as Value in Health and the Journal of Managed Care and Specialty Pharmacy.

Kelly holds a Master of Public Health in Epidemiology from the University of California, Los Angeles and a Bachelor of Science in Behavioral Neuroscience from the University of San Diego.

Authored Content

Placeholder
Cardiovascular

Real-World Adherence and Persistence Among U.S. Medicare Beneficiaries Initiating Advanced Lipid Lowering Therapies

Accepted for presentation at American Society for Preventive Cardiology 2026 Congress on CVD Prevention. Findings available upon request. Contact us for more information.

Placeholder
Hematology, oncology

A Comparative Assessment of Travel Burden and Productivity Loss for CAR T-Cell Therapy and Bispecific Antibody Treatment in Patients With Relapsed/Refractory LBCL Using U.S. Claims Data

Accepted for presentation at International Society for Pharmacoeconomics and Outcomes Research. Findings available upon request. Contact us for more information.

Placeholder
Hematology, oncology

Outcomes of Inpatient and Outpatient Chimeric Antigen Receptor T-Cell Therapy in Newly Authorized Treatment Centers in the United States

Accepted for presentation at American Society of Hematology (ASH). Findings available upon request. Contact us for more information.

A woman wearing glasses holds a tablet and stands in front of a large screen displaying rising bar chart values, suggesting a business presentation on real-world data in healthcare.
Life Sciences

Thriving in Uncertainty: How Real-World Data Powers Life Sciences Resilience

This white paper explores how life sciences can use real-world data to anticipate uncertainty, build resilience, and drive growth.

Read More →
A woman in a business suit and a man in a white lab coat look at a tablet together, appearing focused and engaged, in a bright, modern office setting.
Life Sciences

Opioid Overdose Trends in the U.S., 2021–2024

See how opioid overdose trends have shifted since 2021, including 2024's 26.9% drop in overdose deaths, by insurance type, age, and state.

Read More →